CANCvsHTECETF Comparison
VS
ETF 2
HTEC
Robo Global Healthcare Technology and Innovation ETF
This fund is part of
Multiple Trends
+0.43%
Tema Oncology ETF (CANC) belongs to the Tomorrow's Treatments segment. Robo Global Healthcare Technology and Innovation ETF (HTEC) is part of the Multiple Trends segment. Both ETFs have the same top 3 sector exposures: and Health Care. CANC is more expensive with a Total Expense Ratio (TER) of 0.99%, versus 0.8% for HTEC. CANC is up 8.22% year-to-date (YTD) with +$52M in YTD flows. HTEC performs worse with -1.5% YTD performance, and +$3M in YTD flows. Run a side-by-side ETF comparison of CANC and HTEC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
CANC vs HTEC performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 06/12/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | CANC HTEC | -0.48%+3.59% | +3.95%+7.55% | +8.22%-1.50% | +45.49%+25.79% | n/a+18.79% | n/a-23.98% |
| Flows | CANC HTEC | +$5M+$3K | +$11M+$3M | +$52M+$3M | +$69M+$439K | --$45M | --$89M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | CANC HTEC | +24.37%+24.50% | +22.62%+20.18% | n/a+20.40% | n/a+23.97% |
| Max drawdown | CANC HTEC | -9.20%-7.40% | -9.20%-16.84% | n/a-28.61% | n/a-56.05% |
| Max drawdown duration | CANC HTEC | 54d38d | 54d141d | n/a546d | n/a1744d |
Trading data
CANC | HTEC | |
Last sale 6/15/2026 at 6:14 PM | $37.42 | $35.23 |
| Previous close 06/12/2026 | $37.48 | $34.90 |
| Consolidated volume 06/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of May 29, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
CANC
is actively managed and doesn’t replicate an indexCANC | HTEC | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 6/15/2026 at 6:14 PM
Live
Closed
CANC | HTEC | |
|---|---|---|
| Last price | $37.42 | $35.23 |
| 1D performance | -0.17% | +0.96% |
| AuM | $178.42 M | $55.87 M |
| E/R | 0.99% | 0.8% |
Characteristics
CANC | HTEC | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Tema | ROBO Global ETFs |
| Benchmark | - | ROBO Global Healthcare Technology and Innovation |
| N° of holdings | 42 | 55 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | August 15, 2023 | June 25, 2019 |
| ESG | No | Yes |
Advertisement
Exposure
Countries
CANC
USA
87.11%
Other
12.89%
HTEC
USA
71.03%
Other
28.97%
Sectors
CANC
Health Care
76.64%
Other
23.36%
HTEC
Health Care
86.24%
Other
13.76%
Advertisement
Diversification
CANC
Total weight of top 15 holdings out of 15
54.47%
HTEC
Total weight of top 15 holdings out of 15
30.82%
Top 15 holdings
Data as of April 30, 2026
CANC
REVOLUTION MEDICINES INC
6.51%
IMMUNOME
4.24%
US7711951043
4.15%
COGENT BIOSCIENCES
4.07%
NOVARTIS
4.00%
LILLY
3.81%
ASTRAZENECA
3.62%
BRISTOL-MYERS SQUIBB
3.36%
MERCK & CO INC
3.34%
CELCUITY INC
3.31%
NUVALENT
3.20%
BRIDGEBIO PHARMA
2.84%
US3723032062
2.82%
LEGEND BIOTECH
2.63%
US98887Q1040
2.57%
HTEC
AXOGEN
3.09%
ARROWHEAD PHARMACEUTICALS INC
2.46%
NATERA
2.12%
INTUITIVE SURGICAL
2.00%
ALNYLAM PHARMACEUTICALS
1.98%
VERTEX PHARMACEUTICALS
1.98%
ILLUMINA
1.97%
THERMO FISHER SCIENTIFIC
1.97%
CAREDX INC/D
1.96%
GUARDANT HEALTH INC
1.91%
LIVANOVA
1.90%
GLOBUS MEDICAL
1.88%
GLAUKOS
1.87%
REGENERON PHARMACEUTICALS
1.86%
PENUMBRA
1.86%
Frequently asked questions about CANC and HTEC
How have the CANC and HTEC ETFs performed in 2026?
As of June 12, 2026, CANC is up 8.22% year-to-date (YTD), while HTEC has lost -1.5%. That puts CANC better performer ahead so far this year.
Which ETF is attracting more investor money: CANC or HTEC?
Year-to-date, the CANC ETF saw +$52M in flows, compared to +$3M for HTEC.
Which ETF is more volatile: CANC or HTEC?
Over the past year, CANC had a volatility of 22.62%, while HTEC experienced 20.18%.
Which ETF is bigger: CANC or HTEC?
As of June 12, 2026, CANC holds $178.42 M in assets under management (AUM), while HTEC manages $55.87 M.
What sectors do the CANC and HTEC ETFs invest in?
CANC leans toward sectors like Health Care. Meanwhile, HTEC focuses on Health Care.
What are the top holdings of the CANC ETF and HTEC ETF?
CANC top holdings include REVOLUTION MEDICINES INC, IMMUNOME and US7711951043. HTEC holds in its top three: AXOGEN, ARROWHEAD PHARMACEUTICALS INC and NATERA.
Which ETF is more diversified: CANC or HTEC?
CANC holds 53 securities with 54.47% of its assets in the top 15. HTEC has 55 securities and a top 15 weight of 30.82%.
Advertisement
Latest news about CANC & HTEC
Advertisement
